14-day Premium Trial Subscription Try For FreeTry Free
$3.39
-0.0200 (-0.587%)
At Close: Apr 25, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $3.25 $5.20 Thursday, 25th Apr 2024 AVXL stock ended at $3.39. This is 0.587% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 6.62% from a day low at $3.25 to a day high of $3.47.
90 days $3.25 $6.90
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Apr 28, 2022 $9.10 $9.14 $8.50 $8.99 745 876
Apr 27, 2022 $9.07 $9.37 $8.88 $8.92 638 380
Apr 26, 2022 $9.60 $9.78 $9.03 $9.03 1 120 579
Apr 25, 2022 $9.54 $9.77 $9.42 $9.67 602 786
Apr 22, 2022 $9.84 $10.13 $9.61 $9.64 210 667
Apr 21, 2022 $10.61 $10.64 $9.86 $9.88 858 500
Apr 20, 2022 $10.75 $10.79 $10.40 $10.44 625 500
Apr 19, 2022 $10.56 $10.89 $10.39 $10.73 581 700
Apr 18, 2022 $11.12 $11.12 $10.47 $10.51 933 300
Apr 14, 2022 $11.64 $11.68 $11.08 $11.10 536 116
Apr 13, 2022 $11.27 $11.77 $11.27 $11.67 707 217
Apr 12, 2022 $11.54 $11.89 $11.12 $11.26 495 657
Apr 11, 2022 $11.58 $11.88 $11.28 $11.34 456 313
Apr 08, 2022 $11.95 $12.19 $11.70 $11.80 578 000
Apr 07, 2022 $12.28 $12.46 $11.75 $11.98 585 600
Apr 06, 2022 $12.13 $12.43 $11.82 $12.30 933 500
Apr 05, 2022 $12.85 $12.85 $11.99 $12.04 955 100
Apr 04, 2022 $12.70 $13.00 $12.55 $12.84 766 300
Apr 01, 2022 $12.39 $12.77 $12.33 $12.66 563 608
Mar 31, 2022 $12.36 $12.69 $12.28 $12.28 422 004
Mar 30, 2022 $12.88 $13.08 $12.21 $12.28 567 137
Mar 29, 2022 $12.78 $13.10 $12.73 $12.93 1 024 400
Mar 28, 2022 $12.52 $12.77 $12.32 $12.60 592 100
Mar 25, 2022 $12.85 $12.91 $12.45 $12.48 666 600
Mar 24, 2022 $12.55 $12.89 $12.20 $12.73 754 500
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 11.73% $52.28
LPLA Apr 19 1.08% $262.59
DOOR Apr 18 0.274% $131.39
LNG Apr 17 1.63% $156.81
FCN Apr 16 3.70% $207.62
ELV Apr 16 6.45% $506.97
AKR Apr 05 5.14% $16.53
ITCI Apr 05 5.39% $68.44
SARK Mar 28 14.47% $26.88
ARCC Mar 25 2.53% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT